More than 11,000 bottles of chlorthalidone, a blood pressure medication, are being recalled nationwide due to a manufacturing defect causing failed dissolution specifications. The recall was voluntarily initiated by Inventia Healthcare Limited and covers specific batches distributed in the U.S. by Rising Pharma Holdings. Chlorthalidone is used to treat high blood pressure and reduce swelling related to heart, kidney, or liver disease. The recall affects bottles with batch codes RISA24001 and RISB24002, expiring in April 2027, and is ongoing as per the FDA.
Virtuals Protocol has introduced customizable tokenized indexes on the Robinhood Chain, allowing users to combine multiple assets into a single token. This innovation enables users to create and manage their own asset baskets and earn fees when other...
US spot Bitcoin ETFs saw net inflows of $107.8 million on Wednesday, while Ethereum ETFs attracted $53.8 million, signaling renewed institutional interest in crypto funds. Since their launch in January 2024, Bitcoin ETFs have accumulated over $51 bil...
Kaia has signed a strategic partnership with Xilo Labs to integrate Mochi, an onchain asset management platform, into Kaia's ecosystem. This collaboration allows users to invest stablecoins into diversified portfolios backed by tokenized real-world a...
Bitcoin's price surged to nearly $65,000 following softer-than-expected U.S. inflation data for June, easing fears of Federal Reserve rate hikes. However, on-chain data reveals two main groups of investors—long-term holders who bought near last year'...
Bitcoin miners are experiencing declining revenue as the network's hash rate and mining difficulty fall, reflecting a shift of miners into AI infrastructure. Despite this stress, miners are accumulating Bitcoin, with reserves increasing by 1%, signal...
